- Home
- VCEL vs SPNT Comparison
VCEL vs SPNT Comparison
Compare VCEL & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- SPNT
- Stock Information
- Founded
- VCEL 1989
- SPNT 2011
- Country
- VCEL United States
- SPNT Bermuda
- Employees
- VCEL N/A
- SPNT N/A
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- SPNT Property-Casualty Insurers
- Sector
- VCEL Health Care
- SPNT Finance
- Exchange
- VCEL Nasdaq
- SPNT Nasdaq
- Market Cap
- VCEL 2.1B
- SPNT 1.9B
- IPO Year
- VCEL 1997
- SPNT N/A
- Fundamental
- Price
- VCEL $41.49
- SPNT $19.57
- Analyst Decision
- VCEL Strong Buy
- SPNT Hold
- Analyst Count
- VCEL 8
- SPNT 1
- Target Price
- VCEL $61.75
- SPNT $17.00
- AVG Volume (30 Days)
- VCEL 547.9K
- SPNT 649.3K
- Earning Date
- VCEL 05-08-2025
- SPNT 05-05-2025
- Dividend Yield
- VCEL N/A
- SPNT N/A
- EPS Growth
- VCEL 521.85
- SPNT N/A
- EPS
- VCEL 0.05
- SPNT 0.96
- Revenue
- VCEL $238,541,000.00
- SPNT $2,682,300,000.00
- Revenue This Year
- VCEL $23.23
- SPNT N/A
- Revenue Next Year
- VCEL $24.41
- SPNT $5.79
- P/E Ratio
- VCEL $698.68
- SPNT $20.16
- Revenue Growth
- VCEL 14.80
- SPNT N/A
- 52 Week Low
- VCEL $37.39
- SPNT $11.92
- 52 Week High
- VCEL $63.00
- SPNT $19.74
- Technical
- Relative Strength Index (RSI)
- VCEL 49.55
- SPNT 71.26
- Support Level
- VCEL $37.48
- SPNT $19.13
- Resistance Level
- VCEL $44.41
- SPNT $19.85
- Average True Range (ATR)
- VCEL 1.86
- SPNT 0.63
- MACD
- VCEL 0.61
- SPNT 0.14
- Stochastic Oscillator
- VCEL 58.40
- SPNT 91.84
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.